Doxycycline for Cyst Treatment
Doxycycline is indicated as intralesional sclerotherapy for bone cysts (aneurysmal and unicameral bone cysts) and benign lymphoepithelial cysts, NOT as systemic oral therapy for typical cysts, and is NOT indicated for liver cysts or simple soft tissue cysts.
Primary Indication: Bone Cysts
Doxycycline sclerotherapy has emerged as the primary non-surgical treatment for aneurysmal bone cysts (ABCs) and unicameral bone cysts (UBCs) in the appendicular skeleton and pelvis. The mechanism involves inhibition of matrix metalloproteinases and angiogenesis 1.
Dosing Regimen for Bone Cysts
For intralesional sclerotherapy:
- Doxycycline foam preparation: Mix 2 mL of 50 mg/mL doxycycline with 2 mL of 25% albumin and 1 mL of contrast medium (Isovue 370), then combine with 5 mL of air to create foam 1
- Administration: CT-guided or fluoroscopy-guided percutaneous injection directly into the cyst cavity
- Treatment sessions: Typically requires multiple sessions at 2-3 month intervals (average 6 sessions) 2
- Success rate: 99% treatment success with only 16% recurrence rate, which typically resolves with additional treatment 3
Clinical Outcomes
The evidence strongly supports this approach with excellent safety profile - out of 383 total treatments, only 17 adverse events occurred (mostly SIR Grade 1-2) 3. Patient satisfaction is remarkably high, with 80% reporting little to no pain post-treatment and all patients stating they would undergo the procedure again 3.
Secondary Indication: Benign Lymphoepithelial Cysts (HIV-Associated)
For HIV-associated parotid BLCs:
- Doxycycline used as office-based sclerosant
- Controlled cyst growth in 100% of cases with 12-17 month follow-up 4
- Simple aspiration followed by intralesional doxycycline injection
NOT Indicated For:
Liver Cysts
Despite being studied, doxycycline shows poor penetration into liver cysts with only 1.6% cyst-fluid-to-plasma concentration ratio 5. Trimethoprim (12.2%) and ciprofloxacin (4.2%) demonstrate superior penetration for infected liver cysts 5.
Acne Cysts
When doxycycline is used for severe acne (including cystic acne), it is prescribed as systemic oral therapy as adjunctive treatment, never as monotherapy 6:
Standard oral dosing for acne 6, 7:
- Adults and children >100 lbs: 200 mg on day 1 (100 mg every 12 hours), then 100 mg daily maintenance
- Children ≥8 years and <100 lbs: 2 mg/lb divided into 2 doses on day 1, then 1 mg/lb daily (single or divided doses)
- Contraindicated in children <8 years due to tooth discoloration risk 6
Simple Soft Tissue Cysts
One case report describes attempted doxycycline sclerotherapy for an atypical calf cyst, but resolution likely occurred due to repeated aspiration/fenestration rather than the doxycycline itself 8. This is not an established indication.
Critical Caveats
- Pregnancy Category D: Absolutely contraindicated in pregnancy 6, 7
- Pediatric restrictions: Avoid in children <8 years due to permanent tooth discoloration 6
- Never use as monotherapy for acne - must combine with topical agents 6
- Esophageal protection: Always administer oral forms with adequate fluids to prevent esophagitis 7
- Drug interactions: Reduces efficacy of hormonal contraceptives, oral anticoagulants, and antacids 6
Algorithm for Clinical Decision-Making
Identify cyst type:
- Bone cyst (ABC/UBC) → Intralesional doxycycline sclerotherapy
- HIV-associated parotid BLC → Intralesional doxycycline sclerotherapy
- Infected liver cyst → Use trimethoprim or ciprofloxacin, NOT doxycycline
- Acne cyst → Oral doxycycline as adjunctive therapy only
- Simple soft tissue cyst → Aspiration ± other sclerosants; doxycycline not established
For bone cysts: Refer to interventional radiology for CT/fluoroscopy-guided intralesional foam injection
For acne: Prescribe oral doxycycline with mandatory topical combination therapy